IN2012DN03631A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03631A
IN2012DN03631A IN3631DEN2012A IN2012DN03631A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A IN 3631DEN2012 A IN3631DEN2012 A IN 3631DEN2012A IN 2012DN03631 A IN2012DN03631 A IN 2012DN03631A
Authority
IN
India
Prior art keywords
canines
eye
carotenes
amounts
maladies
Prior art date
Application number
Other languages
English (en)
Inventor
Yuanlong Pan
Wei Wang
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN03631A publication Critical patent/IN2012DN03631A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/01Hydrocarbons
    • A61K31/015Hydrocarbons carbocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN3631DEN2012 2009-10-30 2010-10-22 IN2012DN03631A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28017509P 2009-10-30 2009-10-30
PCT/US2010/002815 WO2011059474A1 (en) 2009-10-30 2010-10-22 Methods for maintaining eye health and ameliorating opthalmic maladies in canines

Publications (1)

Publication Number Publication Date
IN2012DN03631A true IN2012DN03631A (es) 2015-06-26

Family

ID=43991896

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3631DEN2012 IN2012DN03631A (es) 2009-10-30 2010-10-22

Country Status (12)

Country Link
US (1) US20120270954A1 (es)
EP (1) EP2493293B1 (es)
JP (1) JP6071554B2 (es)
CN (1) CN102686107A (es)
AU (1) AU2010318687B2 (es)
BR (1) BR112012010179A2 (es)
CA (1) CA2778229A1 (es)
ES (1) ES2566652T3 (es)
IN (1) IN2012DN03631A (es)
MX (1) MX2012004777A (es)
RU (1) RU2012122169A (es)
WO (1) WO2011059474A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6026719B2 (ja) * 2010-08-31 2016-11-16 株式会社ダイセル 視機能予防・改善剤
WO2013043366A1 (en) * 2011-09-20 2013-03-28 Nestec S.A. Methods and compositions for improving visual function and eye health

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2094060C1 (ru) * 1994-03-22 1997-10-27 Уфимский научно-исследовательский институт глазных болезней Глазная мазь
NZ527924A (en) * 1999-01-29 2005-01-28 Mars Uk Ltd Antioxidant compositions and methods for companion animals
US20020110604A1 (en) * 2000-08-11 2002-08-15 Ashni Naturaceuticals, Inc. Composition exhibiting synergistic antioxidant activity
WO2002082093A2 (en) * 2001-04-02 2002-10-17 Tufts University Methods to measure lipid antioxidant activity
MXPA04011416A (es) 2002-05-17 2005-09-30 Othera Pharmaceuticals Inc Mejora del desarrollo de las cataratas y otras enfermedades oftalmicas.
NZ553731A (en) 2002-05-28 2007-07-27 Altana Pharma Ag Topically applicable pharmaceutical preparation of roflumilast and liquid paraffin
CA2556223A1 (en) * 2004-03-10 2005-09-22 Trustees Of Tufts College Synergistic effect of compositions comprising carotenoids selected from lutein, beta-carotene and lycopene
JP2008515778A (ja) * 2004-08-18 2008-05-15 シリオン セラピューティクス, インコーポレイテッド 眼の状態を13−シス−レチニル誘導体で処置するための組み合わせ方法、組成物および治療
WO2006116755A2 (en) * 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
EP2023945B1 (en) * 2006-06-08 2019-08-07 IAMS Europe B.V. Composition for improving eye health
US8158667B2 (en) 2006-08-21 2012-04-17 Kador Peter F Topical treatment of cataracts in dogs
CN101903045B (zh) 2007-10-19 2013-03-13 株式会社·R-技术上野 用于治疗白内障的药物组合物
CN101939411A (zh) * 2008-02-06 2011-01-05 宝洁公司 用于提高呼吸病症免疫应答的组合物、方法和试剂盒

Also Published As

Publication number Publication date
CN102686107A (zh) 2012-09-19
JP2013509407A (ja) 2013-03-14
EP2493293A1 (en) 2012-09-05
AU2010318687A1 (en) 2012-05-24
JP6071554B2 (ja) 2017-02-01
AU2010318687B2 (en) 2016-02-25
RU2012122169A (ru) 2013-12-10
US20120270954A1 (en) 2012-10-25
EP2493293A4 (en) 2013-03-20
EP2493293B1 (en) 2016-03-02
CA2778229A1 (en) 2011-05-19
WO2011059474A1 (en) 2011-05-19
BR112012010179A2 (pt) 2015-09-29
MX2012004777A (es) 2012-06-01
ES2566652T3 (es) 2016-04-14

Similar Documents

Publication Publication Date Title
MX350951B (es) Composiciones y metodos para tratar enfermedades retinales.
MY151018A (en) Use of nutritional compositions for preventing disorders
MY176679A (en) Use of nutritional compositions for preventing disorders
PH12018500401B1 (en) Antibodies specific for tgf-beta
ECSP099516A (es) Composición suplementaria nutricional para el tratamiento de enfermedades oculares
MX2019004468A (es) Uso de lentes de contacto en el tratamiento de una afeccion oftalmologica.
WO2010105728A3 (en) Active retinal implant
PL2262476T3 (pl) Dostarczanie leku do przedniego i tylnego odcinka oka z użyciem kropli do oczu
MX2007008848A (es) Metodos y composiciones para el tratamiento de desordenes oculares.
WO2007136518A3 (en) Treatment of autoimmune disorders
CL2008003120A1 (es) Compuestos derivados de fenilalquil-, fenilalquenil-, fenilalquinil- amina, feniltioalquilamina, fenilaminoalquilamina, fenilalcoxiamina y fenilalquilguanidina; composicion farmaceutica; y uso de los compuestos para tratar un trastorno o enfermedad oftalmologica tal como retinopatia, maculopatia, retinitis pigmentosa, uveitis, entre otras.
SG156649A1 (en) Crig polypeptide for prevention and treatment of complement-associated disorders
MX2007010752A (es) Usos oftalmicos de moduladores de receptor s1p.
WO2011151685A8 (en) N-acetyl-dl-leucine, neuroprotective and retinoprotective medicament
TN2010000566A1 (en) Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
WO2007135426A3 (en) Treatment of neurodegeneratives diseases
IN2012DN03631A (es)
HK1077306A1 (en) Ocular gene therapy
Kim Hyaluronic acid
Clarke Non-arteritic anterior ischaemic optic neuropathy: case report
Law Intracranial hypertension: case report
De Rojas Bilateral choroidal effusion: case report
Santos-Bueso Sodium aurothiomalate
RU2016131144A (ru) Способы облегчения глазных болезней у псовых
Bahali Mydriasis: case report